CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) MUTATIONS DETECTION COMPREHENSIVE PANEL Test
At DNA Labs UAE, we offer the CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) MUTATIONS DETECTION COMPREHENSIVE PANEL Test. This diagnostic test is designed to identify specific genetic mutations in patients with CLL, a type of cancer that affects the lymphocytes, a type of white blood cell.
Test Components:
- SF3B1 K700E mutation
- MYD88 L265P mutation
- NOTCH1 p.2514 fs mutation
- PTEN loss at 10q23.31
- 11q deletion
- Trisomy 12
- 13q14 deletion
- 14q deletion
- 17p deletion
- Trisomy 19
- Chromosome 2p gain
- 6q deletion
- 8p loss & 8q amplification
- 9p21 loss
Price: 1400.0 AED
Sample Condition:
4 mL (2 mL min.) whole blood from 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Report Delivery:
SampleMon by 11 am; ReportSat
Method:
PCR – MLPA
Test Type:
Cancer
Doctor:
Oncologist
Test Department:
MOLECULAR DIAGNOSTICS
Pre Test Information:
Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Test Details:
The Chronic Lymphocytic Leukemia (CLL) Mutations Detection Comprehensive Panel Test is a diagnostic test used to identify specific genetic mutations in patients with CLL. This panel test analyzes multiple genes known to be associated with CLL, including TP53, NOTCH1, SF3B1, ATM, and others. These genes are frequently mutated in CLL and can provide important information about the prognosis and treatment options for the patient.
The test is typically performed on a blood or bone marrow sample from the patient. The DNA from the sample is extracted and sequenced to identify any mutations or changes in the targeted genes. The results of the test can help guide treatment decisions, as certain mutations may indicate a higher risk of disease progression or resistance to certain therapies.
Overall, the CLL Mutations Detection Comprehensive Panel Test is a valuable tool in the management of CLL, providing important genetic information that can help personalize treatment plans for patients.
| Test Name | CHRONIC LYMPHOCYTIC LEUKEMIA CLL MUTATIONS DETECTION COMPREHENSIVE PANEL Test |
|---|---|
| Components | *SF3B1 K700E mutation*MYD88 L265P mutation*NOTCH1 p.2514 *fs mutation *PTEN loss at 10q23.31*11q deletion *Trisomy 12 *13q14 deletion*14q deletion*17p deletion*Trisomy 19 *Chromosome 2p gain*6q deletion*8p loss & 8q amplification*9p21 loss |
| Price | 1400.0 AED |
| Sample Condition | 4 mL (2 mL min.) whole blood from 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory. |
| Report Delivery | SampleMon by 11 am;ReportSat |
| Method | PCR – MLPA |
| Test type | Cancer |
| Doctor | Oncologist |
| Test Department: | MOLECULAR DIAGNOSTICS |
| Pre Test Information | Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory. |
| Test Details | The Chronic Lymphocytic Leukemia (CLL) Mutations Detection Comprehensive Panel Test is a diagnostic test used to identify specific genetic mutations in patients with CLL. CLL is a type of cancer that affects the lymphocytes, a type of white blood cell. This panel test analyzes multiple genes known to be associated with CLL, including TP53, NOTCH1, SF3B1, ATM, and others. These genes are frequently mutated in CLL and can provide important information about the prognosis and treatment options for the patient. The test is typically performed on a blood or bone marrow sample from the patient. The DNA from the sample is extracted and sequenced to identify any mutations or changes in the targeted genes. The results of the test can help guide treatment decisions, as certain mutations may indicate a higher risk of disease progression or resistance to certain therapies. Overall, the CLL Mutations Detection Comprehensive Panel Test is a valuable tool in the management of CLL, providing important genetic information that can help personalize treatment plans for patients. |
